23

October 23, 2014

Natural product-based therapy for DM: Agaricus bisporus lectins inhibit gluconeogenesis and hyperglycemia via up regulation of Cyclin D1., Genome-2-Bio-Medicine Discovery center (GBMD), 23/10/2014, 22.42

A study from the Department of Cancer Biology, Dana-Farber Cancer Institute;  Department of Cell Biology, Harvard Medical School, USA; and others shows that “Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression.” This […]
October 23, 2014

MiRNA-based therapy for Pulmonary arterial Hypertension: Endothelin-1 exacerbates pulmonary arterial hypertension through up regulation of its target gene, 23/October/2014, 22.26

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, MiRNA-based therapy for Pulmonary arterial Hypertension: Endothelin-1 exacerbates pulmonary arterial hypertension through up regulation of its target gene, 23/October/2014, 22.26, Genome-2-Bio-Medicine Discovery […]
October 23, 2014

Insights into the treatment of Fibrosis: Tumor suppressor BMP4 suppresses the expression of TGFß receptor II (TGFBR2) and extracellular matrix proteins via up regulation of its target gene, 23/October/2014, 14.43

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, Insights into the treatment of Fibrosis: Tumor suppressor BMP4 suppresses the expression of TGFß receptor II (TGFBR2)  and extracellular […]
October 23, 2014

Treating cancer with an NIDDM drug: Acarbose, the widely used drug in the treatment of T2D, suppresses the expression of Notch1 and Notch2 via up regulation of its target gene, 23/October/2014, 14.36

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, Treating cancer with an NIDDM drug: Acarbose, the widely used drug in the treatment of T2D, suppresses the expression of […]